Cox Proportional Hazard Models are nothing new to those who follow oncology drugs where the statistical analysis is used to calculate survival effects of drugs. But the Alliance Life Sciences Consulting Group Inc. put an interesting twist on the statistical analysis, using it to determine what factors affect the price changes of oncology drugs. Read More
The FDA is your friend. Controversial as that sentiment may be among drug developers, it is the opinion of Lawrence Friedhoff, developer of Alzheimer's drug Aricept (donepezil, Pfizer Inc.) and number of other drugs. Read More
The U.S. Small Business Administration has updated its regulations regarding the size and eligibility for Small Business Innovation Research and Small Business Technology Transfer programs, which take effect Jan. 28. Read More
